About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Everolimus Related Pneumonitis in MBC

NCT03730428·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fudan University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Postmenopausal woman (or premenopausal women treated with LHRHa) diagnosed with HR+，HER2- metastatic breast cancer
2. Treated with everolimus for at least one month in metastatic setting
3. With baseline and at least one follow-up chest CT during everolimus therapy.
4. Complete medical history

You may not be if

1. Incomplete medical history
2. Radiographic imaging unavailable

The record

StatusCompleted

PhaseNo phase

Taking part86

StartedJul 2017

UpdatedAug 18, 2020

Conditions

Everolimus Pneumonitis

Where1

Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China

Clareo Health | Everolimus Related Pneumonitis in MBC